- Home
- RGNX vs EVGO Comparison
RGNX vs EVGO Comparison
Compare RGNX & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- EVGO
- Stock Information
- Founded
- RGNX 2008
- EVGO 2010
- Country
- RGNX United States
- EVGO United States
- Employees
- RGNX N/A
- EVGO N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- EVGO Other Specialty Stores
- Sector
- RGNX Health Care
- EVGO Consumer Discretionary
- Exchange
- RGNX Nasdaq
- EVGO Nasdaq
- Market Cap
- RGNX 387.0M
- EVGO 376.5M
- IPO Year
- RGNX 2015
- EVGO N/A
- Fundamental
- Price
- RGNX $8.18
- EVGO $3.64
- Analyst Decision
- RGNX Strong Buy
- EVGO Strong Buy
- Analyst Count
- RGNX 8
- EVGO 10
- Target Price
- RGNX $31.75
- EVGO $5.78
- AVG Volume (30 Days)
- RGNX 1.2M
- EVGO 4.1M
- Earning Date
- RGNX 05-12-2025
- EVGO 05-06-2025
- Dividend Yield
- RGNX N/A
- EVGO N/A
- EPS Growth
- RGNX N/A
- EVGO N/A
- EPS
- RGNX N/A
- EVGO N/A
- Revenue
- RGNX $156,718,000.00
- EVGO $276,954,000.00
- Revenue This Year
- RGNX $285.14
- EVGO $39.88
- Revenue Next Year
- RGNX N/A
- EVGO $32.26
- P/E Ratio
- RGNX N/A
- EVGO N/A
- Revenue Growth
- RGNX 80.70
- EVGO 45.15
- 52 Week Low
- RGNX $5.04
- EVGO $1.78
- 52 Week High
- RGNX $17.52
- EVGO $9.07
- Technical
- Relative Strength Index (RSI)
- RGNX 51.88
- EVGO 68.52
- Support Level
- RGNX $6.89
- EVGO $3.61
- Resistance Level
- RGNX $10.59
- EVGO $3.94
- Average True Range (ATR)
- RGNX 0.76
- EVGO 0.25
- MACD
- RGNX -0.16
- EVGO 0.10
- Stochastic Oscillator
- RGNX 34.86
- EVGO 67.59
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.